References
1. USP-DI (United States Pharmacopeial Convention Inc., 17th ed., Rockville, MD, 1997), p. 1788.
2. Physician's Desk Reference (Thomson PDR, 57th ed., Montvale, NJ, 2003), p. 2942.
3. M. Mori et al., "Prolongation of Antipyretic Action and Reduction of Gastric Ulcerogenicity in the Rat by Controlled-Release
Granules of Bermoprofen, a New Nonsteroidal Anti-Inflammatory Drug," J. Pharm. Sci.
80, 876–880 (1991).
4. J. Rovensky and D. Micekova, "Six-Month Prospective Study to Monitor the Treatment of Rheumatic Diseases with Sustained-Release
Flurbiprofen," Drug. Exp. Clin. Res.
26, 19–24 (2000).
5. T. Lee and J.R. Robinson, "Controlled-Release Drug-Delivery Systems," in Remington: The Science and Practice of Pharmacy (Lippincott Williams & Wilkins, 20th ed., Baltimore, MD, 2000), pp. 903–904.
6. L. Genc and N. Hegazy, "Sustained-Release Wax Matrix Formulations of Ketorolac Tromethamine with Compritol 888 ATO and
HD 5 ATO," Acta Pharm. Turcia
42, 39–45 (2000).
7. D.M. Brahmankar, R.M. Karwa, and S.B. Jaiswal, "Cellulose Matrices for Controlled Release of Ketorolac Tromethamine,"
Indian Drugs
33, 120–123 (1996).
8. N. Vatsaraj, H. Zia, and T. Needham, "Formulation and Optimization of a Sustained-Release Tablet of Ketorolac Tromethamine,"
Drug Delivery
9, 153–159 (2002).
9. A.P. Rokhade et al., "Semi-Interpenetrating Polymer Network Microspheres of Gelatin and Sodium Carboxymethyl Cellulose
for Controlled Release of Ketorolac Tromthamine," Carbohydrate Polymers
65, 243–252 (2006).
10. K. Ruckmani, M.S. Muneera, and R. Vijaya, "Eudragit Matrices for Sustained Release of Ketorolac Tromethamine and Kinetics
of Release," Bollettino Chimico Farmaceutico
139, 205–208 (2000).
11. E.A. Hosny, A.A. Al-Helm, and E.M. Niazy, "In Vitro and In Vivo Evaluation of Commercial and Microcapsulated Sustained-Release Tablets Containing Diclofenac Sodium," Saudi Pharm. J.
6, 65–70 (1998).
12. M. Khan, J. Dib, and I.K. Reddy, "Statistical Optimization of Ketoprophen-Eudragit S-100 Coprecipitates to Obtain Controlled-Release
Tablets," Drug Dev. Ind. Pharm.
22, 135–141 (1996).
13. C. Ho and G.C. Hwang, "Development of Extended-Release Solid Dispersions of Nonsteroidal Anti-Inflammatory Drugs with
Aqueous Polymeric Dispersions: Optimization of Drug Release via a Curve-Fitting Technique," Pharm. Res.
9, 206–210 (1992).
14. J. Staniforth, "Powder Flow," in Pharmaceutics: The Science of Dosage Form Design, M.E. Aulton, Ed. (Churchill Livingstone, 2nd ed., Edinburgh, Scotland, 2002), pp. 205–207.
15. USP 26–NF 21 (United States Pharmacopeial Convention Inc., Rockville, MD, 2002), pp. 978–980.
16. R.K. Chang and A.J. Shukla, "Polymethacrylates," in Handbook of Pharmaceutical Excipients, R.C. Rowe, P.J. Shesky, and P.J. Weller, Eds. (Pharmaceutical Press, 4th ed., London, England, 2002), pp. 462–468.
17. L. Genc, E. Guler, and N. Hegazy, "Film-Coated Enteric Tablet Formulation of Ketorolac Tromethamine," Drug Dev. Ind. Pharm.
23, 1007–1011 (1997).
18. T. Higuchi, "Mechanism of Sustained Action Medication. Theoretical Analysis of Rate Release of Solid Drugs Dispersed
in Solid Matrices," J. Pharm. Sci.
52, 1145–1149 (1963).
19. M. Donbrow, and S. Benita, "Release Kinetics of Sparingly Soluble Drugs from Ethyl Cellulose–Walled Microcapsules: Salicylamide
Microcapsules," J. Pharm. Pharmacol.
34, 547–551 (1982).
20. Z. Qiu et al., "Effect of Milling and Compression on the Solid-State Maillard Reaction," J. Pharm. Sci.
94, 2568–2580 (2005).
21. R.C. George et al., "Investigation into the Yellowing on Aging of Sabril Tablet Cores," Drug Dev. Ind. Pharm.
20, 3023–3032 (1994).
|
